×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CMPX – compass therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CMPX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
05:12 pm
cmpx
Compass Therapeutics, Inc. (CMPX) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Compass Therapeutics, Inc. (CMPX) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
12/3
09:11 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $10.00 price target on the stock.
Low
Report
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $10.00 price target on the stock.
12/3
08:06 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $10.00 price target on the stock.
12/3
07:19 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Medium
Report
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
12/3
07:18 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) was given a new $10.00 price target on by analysts at JMP Securities.
Medium
Report
Compass Therapeutics (NASDAQ:CMPX) was given a new $10.00 price target on by analysts at JMP Securities.
12/3
06:04 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
Low
Report
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
12/1
03:28 am
cmpx
Compass Therapeutics (CMPX) Is Up 17.2% After Analyst Highlights Pipeline Progress and Anticipated Tovecimig Data – Has the Bull Case Changed? [Yahoo! Finance]
Medium
Report
Compass Therapeutics (CMPX) Is Up 17.2% After Analyst Highlights Pipeline Progress and Anticipated Tovecimig Data – Has the Bull Case Changed? [Yahoo! Finance]
12/1
01:22 am
cmpx
Strong Analyst Confidence in Compass Therapeutics (CMPX) Driven by CTX-10726 Advancement [Yahoo! Finance]
Medium
Report
Strong Analyst Confidence in Compass Therapeutics (CMPX) Driven by CTX-10726 Advancement [Yahoo! Finance]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/18
08:31 am
cmpx
Form 4 Compass Therapeutics, For: Nov 16 Filed by: Schuetz Thomas J.
Low
Report
Form 4 Compass Therapeutics, For: Nov 16 Filed by: Schuetz Thomas J.
11/14
06:36 pm
cmpx
Form SCHEDULE 13G Compass Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
Low
Report
Form SCHEDULE 13G Compass Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
11/14
04:22 pm
cmpx
Form SCHEDULE 13G/A Compass Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
Low
Report
Form SCHEDULE 13G/A Compass Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
11/14
04:19 pm
cmpx
Form SCHEDULE 13G/A Compass Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
Low
Report
Form SCHEDULE 13G/A Compass Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
11/5
07:31 am
cmpx
Form 10-Q Compass Therapeutics, For: Sep 30
Low
Report
Form 10-Q Compass Therapeutics, For: Sep 30
11/5
07:30 am
cmpx
Form 8-K Compass Therapeutics, For: Nov 05
Low
Report
Form 8-K Compass Therapeutics, For: Nov 05
10/29
05:25 pm
cmpx
Form SCHEDULE 13G Compass Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Medium
Report
Form SCHEDULE 13G Compass Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: